Cat Pinnaro, MD

Contact Information 

Office: 216 MERF 
Phone: 335-8256

Brief description of current research: 

Dr. Pinnaro’s research focuses on clinical phenotyping of diabetes associated with genetic syndromes. By coupling phenotyping and genomics, she ultimately hopes to elucidate the pathophysiology and genetic etiology. Her most recent study evaluated impaired glucose tolerance in girls and women with Turner syndrome using both oral glucose tolerance tests and continuous glucose monitoring. She is also active in clinical and database studies related to type 1 diabetes with an emphasis in diabetes technology.

3 most influential diabetes/obesity/metabolism publications:

  •  Pinnaro CT. Ode, KL., Tansey, MJ, Tsalikian E, & Norris AW. Impaired glucose tolerance Is prevalent in adolescents and women with Turner syndrome with normal hemoglobin A1c. Submitted July 2020.
  • O’Malley G., Ebekozien O., Desimone M., Pinnaro CT, Roberts AJC., Polsky S, Noor N, Aleppo G, Basina MM, Tansey MJ, Steenkamp D, Vendrame F, Lorincz I, Mathias P, Agarwal S, Golden L, Hirsch IB, Weinstock R, Levy CJ. COVID-19 hospitalization in adults with type 1 diabetes: results from the T1D Exchange multi-center surveillance study. Submitted July 2020.
  • ​Alonso GT, Ebekozien O, Wood JR, Rompicherla S, Lyons SK, Choudhary A, Majidi S, Pinnaro CT, Balachandar S, Gangat M, Roberts AJC, Marks BE, Creo A, Sanchez J, Seeherunvong T, Jiminez-Vega J, Patel NS, Gabriel L, Sumpter KM, Wilkes M, Rappaport R, Cymbaluk A, Wong JC, Gallagher MP, Srinath S, Albanese-O’Neill A. Increased risk of hospitalization with COVID-19 among children with type 1 diabetes and elevated A1c. Submitted July 2020


"I love my job. Every day I wake up and think, I don't have to do this, I get to do this!"